acut
respiratori
distress
syndrom
ard
immunedriven
patholog
observ
sever
case
sever
acut
respiratori
syndrom
coronaviru
sarscov
infect
sarscov
emerg
led
global
outbreak
sar
outcom
human
infect
intranas
infect
mice
mouseadapt
sarscov
result
hightit
viru
replic
within
lung
induct
inflammatori
cytokin
chemokin
immun
cell
infiltr
within
lung
use
model
investig
role
complement
system
sarscov
infect
observ
activ
complement
cascad
lung
earli
day
follow
sarscov
infect
test
whether
activ
contribut
protect
patholog
outcom
util
mice
defici
central
compon
complement
system
rel
control
mice
sarscovinfect
mice
exhibit
significantli
less
weight
loss
less
respiratori
dysfunct
despit
equival
viral
load
lung
significantli
fewer
neutrophil
inflammatori
monocyt
present
lung
mice
control
subsequ
studi
reveal
reduc
lung
patholog
lower
cytokin
chemokin
level
lung
sera
mice
control
studi
identifi
complement
system
import
host
mediat
sarscovinduc
diseas
suggest
complement
activ
regul
system
proinflammatori
respons
sarscov
infect
furthermor
data
suggest
sarscovmedi
diseas
larg
immun
driven
inhibit
complement
signal
sarscov
infect
might
function
effect
immun
therapeut
import
complement
system
critic
part
host
defens
mani
bacteri
viral
fungal
infect
work
alongsid
pattern
recognit
receptor
stimul
host
defens
system
advanc
activ
adapt
immun
respons
studi
directli
test
role
complement
sarscov
pathogenesi
use
mous
model
show
respiratori
diseas
significantli
reduc
absenc
complement
even
though
viral
load
unchang
complementdefici
mice
reduc
neutrophilia
lung
reduc
system
inflamm
consist
observ
sarscov
pathogenesi
immunedriven
diseas
data
suggest
inhibit
complement
signal
might
effect
treatment
option
follow
coronaviru
infect
coronavirus
circul
anim
market
china
emerg
novel
viru
led
global
outbreak
respiratori
diseas
human
case
mortal
new
relat
zoonot
coronaviru
identifi
middl
east
design
middl
east
respiratori
syndrom
coronaviru
merscov
caus
sever
respiratori
diseas
greater
mortal
www
whointemergenciesmerscoven
sarscov
merscov
caus
rang
diseas
asymptomat
case
sever
acut
respiratori
distress
syndrom
ard
respiratori
failur
notabl
metagenom
synthet
viru
recoveri
strategi
sinc
reveal
exist
larg
pool
preepidem
sarslik
bat
coronavirus
replic
primari
human
airway
epitheli
cell
virus
pois
emerg
effici
use
human
entri
receptor
resist
exist
vaccin
immunotherapeut
due
ongo
threat
continu
emerg
new
highli
pathogen
coronavirus
anim
reservoir
thorough
understand
hostviru
interact
drive
sarscov
pathogenesi
aid
public
health
respons
current
futur
coronaviru
outbreak
import
complement
sarscov
pathogenesi
controversi
previou
studi
investig
role
known
polymorph
mannosebind
lectin
mbl
mblassoci
serin
gene
sarscov
infect
outcom
follow
outbreak
conflict
result
one
retrospect
analysi
show
peopl
low
defici
serum
mbl
level
like
becom
infect
sarscov
high
mbl
level
suggest
mbl
complement
activ
play
role
protect
host
infect
howev
second
studi
found
associ
mbl
haplotyp
sarscov
infect
statu
addit
shown
mbl
bind
sarscov
spike
protein
vitro
group
other
examin
role
downstream
complement
gene
found
associ
genotyp
sar
suscept
togeth
result
leav
gener
uncertainti
role
complement
respons
sarscov
infect
despit
exist
bodi
literatur
role
complement
sarscov
pathogenesi
never
directli
assess
vivo
complement
system
ancient
arm
innat
immun
respons
compris
multipl
protein
whose
reactiv
cascad
cleavag
product
coordin
inflammatori
respons
site
infect
directli
antimicrobi
consist
solubl
cell
surfaceassoci
protein
complement
major
compon
innat
immun
function
recogn
elimin
invad
pathogen
activ
complement
system
occur
multipl
mechan
includ
three
welldescrib
pathway
classic
lectin
altern
complement
activ
pathway
result
proteolyt
process
variou
compon
complement
system
includ
proteolyt
process
gener
array
cleavag
product
involv
amplif
complement
activ
format
convertas
opson
pathogen
attract
activ
leukocyt
innat
adapt
arm
immun
respons
sever
studi
includ
recent
studi
show
complement
blockad
result
reduc
diseas
merscov
human
transgen
mous
model
elucid
protect
pathogen
role
complement
system
follow
infect
varieti
viral
pathogen
furthermor
complement
system
welldescrib
role
pulmonari
diseas
especi
influenza
viru
respiratori
syncyti
viru
infect
studi
assess
role
complement
system
pathogenesi
sarscov
infect
build
system
biolog
analysi
suggest
complement
modul
sarscov
infect
confirm
complement
activ
upon
sarscov
challeng
mice
defici
central
protein
complement
signal
pathway
protect
sarscovinduc
weight
loss
reduc
patholog
improv
respiratori
function
lower
level
inflammatori
cytokineschemokin
lung
peripheri
importantli
kinet
magnitud
viru
replic
wildtyp
mice
show
complement
play
role
control
viru
replic
observ
complement
deposit
lung
sarscovinfect
mice
suggest
complement
activ
result
immunemedi
damag
lung
addit
serum
activ
indic
complementmedi
system
inflamm
may
drive
pathogen
respons
sarscov
infect
togeth
result
indic
complement
play
critic
role
sarscov
pathogenesi
inhibit
complement
pathway
might
effect
therapeut
coronavirusmedi
diseas
complement
activ
sarscov
mice
work
laboratori
shown
mice
extrem
suscept
influenza
viru
infect
role
complement
sarscov
infect
yet
evalu
vivo
use
system
biologybas
approach
identifi
complement
pathway
highprior
target
control
sarscov
mouseadapt
sarscov
pathogenesi
base
weight
gene
correl
network
analysi
wgcna
rna
transcript
lung
mice
infect
lethal
versu
subleth
dose
sarscov
complement
signal
cascad
activ
proteolyt
cleavag
event
also
assess
lung
proteom
sampl
complement
protein
abund
cfb
significantli
higher
abund
lung
mice
infect
lethal
dose
sarscov
mice
infect
subleth
dose
fig
complement
activ
measur
detect
pathway
compon
cleavag
product
master
regul
complement
signal
cleav
follow
creation
convertas
activ
product
fragment
detect
western
blot
lung
tissu
sarscov
mice
control
mice
earli
day
postinfect
dpi
fig
confirm
sarscov
infect
activ
complement
pathway
test
import
complement
signal
pathway
sarscov
pathogenesi
infect
mice
control
sarscov
control
mice
exhibit
approxim
transient
weight
loss
peak
weight
loss
day
postinfect
fig
contrast
mice
significantli
protect
infect
signific
weight
loss
evid
time
point
surprisingli
viral
titer
lung
similar
control
fig
indic
lack
diseas
mice
uncoupl
viral
replic
effici
complement
signal
necessari
sarscov
clearanc
lung
measur
sarscov
diseas
assess
respiratori
function
use
wholebodi
plethysmographi
follow
infect
mice
enhanc
paus
penh
calcul
measur
airway
resist
associ
airway
debri
follow
sarscov
infect
exhal
forc
measur
exhal
forc
midbreath
increas
breath
becom
difficult
final
ratio
peak
expiratori
flow
rpef
time
peak
expiratori
flow
associ
wheez
follow
infect
three
metric
shown
chang
significantli
follow
sarscov
infect
penh
increas
follow
infect
rpef
decreas
combin
measur
show
sarscov
anim
alter
exhal
pattern
breath
mice
exhibit
decreas
chang
penh
level
follow
sarscov
infect
rel
infect
control
mice
howev
rpef
valu
similar
infect
condit
fig
e
togeth
data
indic
despit
lack
weight
loss
mice
absenc
complement
pathway
alter
host
control
viral
respiratori
function
sarscov
mice
mockinfect
mice
measur
use
buxco
wholebodi
plethysmographi
system
penh
measur
calcul
airway
resist
c
midbreath
expiratori
flow
rpef
rate
peak
expiratori
flow
e
p
mockinfect
mice
given
condit
c
e
three
mice
use
infect
group
two
mockinfect
mice
use
replic
complet
abolish
respiratori
diseas
follow
sarscov
infect
order
determin
arm
complement
pathway
contribut
sarscov
pathogenesi
infect
knockout
mice
lack
compon
upstream
mice
lack
abil
signal
classic
lectin
pathway
fbdefici
mice
lack
abil
signal
altern
pathway
mous
strain
show
reduc
weight
loss
rel
infect
control
mice
see
fig
supplement
materi
day
postinfect
howev
neither
fb
mice
reproduc
complet
protect
weight
loss
observ
control
togeth
result
suggest
multipl
arm
complement
pathway
may
activ
contribut
sarscovmedi
diseas
activ
reduc
lung
patholog
mice
analysi
sarscov
lung
section
show
absenc
result
reduc
still
signific
lung
patholog
day
postinfect
minor
effect
lung
diseas
observ
airway
denud
debri
main
histopatholog
phenotyp
earli
time
point
level
patholog
similar
wildtyp
knockout
mice
fig
tabl
mice
exhibit
airspac
inflamm
includ
eosino
phil
dpi
wildtyp
control
although
relationship
revers
later
infect
dpi
mice
display
pronounc
lung
patholog
includ
inflammatori
cell
larg
airway
parenchyma
perivascular
cuf
thicken
interstiti
membran
low
level
intraalveolar
edema
contrast
mice
show
reduc
score
area
consist
improv
respiratori
function
observ
fig
notabl
lung
patholog
result
pronounc
complet
absenc
weight
loss
suggest
possibl
distinct
lung
diseas
overal
pathogenesi
also
consid
whether
decreas
sarscov
pathogenesi
mice
due
reduc
lung
damag
absenc
complement
pathway
signal
investig
possibl
look
sign
complement
deposit
sarscov
lung
tissu
dpi
observ
scatter
posit
stain
complement
lung
sarscov
mice
suggest
local
tissu
damag
might
contribut
sarscov
pathogenesi
fig
interestingli
stain
consist
found
parenchyma
lung
larg
airway
main
site
sarscov
replic
posit
stain
observ
lung
mice
diminish
infiltr
lung
select
immun
popul
infect
mice
order
identifi
quantit
inflammatori
cell
lung
perform
flow
cytometri
dpi
parallel
human
exhibit
lung
patholog
mice
exhibit
signific
pulmonari
infiltr
follow
sarscov
infect
inflamm
reduc
rel
observ
wildtyp
mice
sarscov
mice
similar
total
cell
count
well
similar
percentag
cell
lung
data
shown
consist
observ
human
sarscov
patient
lymphopenia
observ
lung
sarscov
mice
reduc
percentag
b
cell
fig
cell
rel
mockinfect
mice
follow
infect
despit
similar
overal
lymphocyt
level
small
signific
differ
observ
level
cell
activ
infect
mice
cell
mice
express
fig
intracellular
marker
prolifer
control
analysi
myeloid
cell
lung
show
infect
mice
significantli
higher
level
neutrophil
particularli
nonactiv
neutrophil
lung
infect
mice
fig
e
furthermor
inflammatori
monocyt
previous
associ
increas
sarscov
pathogenesi
significantli
increas
lung
wildtyp
mice
mice
fig
final
observ
significantli
dendrit
cell
alveolar
macrophag
lung
sarscov
mice
lung
infect
mice
togeth
although
mice
produc
robust
immun
cell
infiltr
follow
sarscov
infect
signific
reduct
inflammatori
monocyt
neutrophil
rel
control
cell
type
associ
sarscov
pathogenesi
convers
presenc
activ
cell
associ
recoveri
follow
infect
addit
examin
inflammatori
cell
evalu
vascular
integr
lung
follow
sarscov
infect
presenc
absenc
observ
differ
number
platelet
present
bronchoalveolar
lavag
bal
fluid
mice
either
day
postinfect
indic
absenc
appear
significantli
alter
vascular
permeabl
follow
infect
sarscov
fig
cytokin
chemokin
level
significantli
decreas
lung
mice
investig
inflammatori
respons
sarscov
infect
measur
cytokin
chemokin
protein
level
lung
presenc
absenc
complement
signal
multipl
protein
express
pattern
observ
respons
infect
highli
express
lung
follow
sarscov
infect
mice
fig
indic
inflammatori
signal
remain
intact
absenc
granulocyt
colonystimul
factor
gcsf
interleukin
tumor
necrosi
factor
alpha
compris
group
cytokin
chemokin
highli
produc
lung
mice
mice
fig
peak
day
postinfect
notabl
cytokin
role
product
recruit
differenti
neutrophil
consist
flow
cytometri
result
fig
except
rant
inflammatori
cytokin
chemokin
measur
highest
level
dpi
indic
host
immun
respons
trigger
quickli
follow
infect
sarscov
togeth
result
indic
absenc
complement
impact
magnitud
cytokin
chemokin
lung
howev
robust
product
occur
either
presenc
absenc
sarscov
induc
system
complement
activ
absenc
complement
signal
result
reduc
sarscov
pathogenesi
measur
weight
loss
partial
reduct
respiratori
dysfunct
patholog
immun
infiltr
cytokin
respons
lung
hypothes
system
diseas
coupl
chang
viral
titer
might
also
drive
import
element
complementmedi
diseas
therefor
examin
sera
wildtyp
mice
sign
system
diseas
follow
infect
western
blot
analysi
show
increas
level
fragment
serum
indic
system
complement
activ
sarscov
mice
dpi
fig
given
result
next
examin
cytokin
chemokin
protein
level
marker
inflamm
sera
sarscov
mice
rant
level
elev
serum
follow
infect
regardless
mous
genet
background
fig
howev
numer
cytokin
chemokin
gcsf
kc
keratinocyt
chemoattract
present
significantli
higher
abund
lung
mice
knockout
mice
fig
examin
possibl
sarscov
infect
lead
complement
deposit
outsid
lung
found
sign
increas
complement
stain
kidney
fig
although
complement
deposit
seen
presenc
activ
complement
inflammatori
cytokin
sera
like
contribut
system
inflammatori
respons
drive
sarscov
weight
loss
follow
infect
complement
system
critic
part
host
immun
respons
bacteri
viral
infect
origin
identifi
heatsensit
nonspecif
complement
specif
adapt
immun
pathway
complement
system
one
way
innat
immun
system
detect
respond
foreign
antigen
potenti
damag
host
tissu
complement
system
also
tightli
regul
number
inhibit
protein
constitut
present
serum
previous
shown
complement
pathway
signal
critic
protect
host
immun
respons
variou
bacteri
infect
well
influenza
viru
flaviviru
infect
furthermor
virus
includ
herpesvirus
poxvirus
astrovirus
flavivirus
retrovirus
encod
gene
help
evad
detect
complement
system
strong
evid
complement
import
host
antivir
respons
host
factor
drive
protect
pathogen
complementassoci
respons
viral
infect
well
understood
particular
concern
anaphylatoxin
produc
activ
complement
signal
cascad
potent
proinflammatori
properti
trigger
inflammatori
cell
recruit
neutrophil
activ
blockad
propos
treatment
acut
lung
injuri
antibodi
shown
protect
mice
infect
influenza
viru
recent
merscov
complement
recognit
import
control
paramyxovirus
dengu
viru
human
lymphotroph
viru
type
mani
virus
develop
mean
evad
detect
complement
system
contrast
data
present
conjunct
recent
find
ross
river
viru
influenza
viru
wellestablish
autoimmun
diseas
demonstr
complement
system
activ
also
lead
exacerb
diseas
previou
report
clearli
establish
abil
mannosebind
lectin
mbl
bind
sarscov
spike
protein
depend
nlink
glycosyl
site
howev
role
complement
signal
sarscov
pathogenesi
unclear
studi
demonstr
complement
system
activ
follow
sarscov
infect
fig
howev
observ
chang
viral
titer
mice
fig
indic
import
differ
vivo
vitro
studi
use
viral
pseudoparticl
absenc
complement
signal
result
protect
sarscov
weight
loss
shown
use
mice
fig
activ
pathwayspecif
knockout
mice
fig
respiratori
function
knockout
mice
improv
rel
control
mice
although
signific
chang
penh
rpef
still
observ
indic
elimin
complement
signal
complet
remov
effect
sarscov
infect
analysi
cellular
inflammatori
respons
sarscov
infect
reveal
modest
chang
histopatholog
overal
inflammatori
cell
recruit
lung
signific
differ
observ
pathogen
inflammatori
monocyt
neutrophil
popul
indic
complement
signal
contribut
broader
immun
respons
infect
immunohistochem
stain
reveal
sarscov
infect
induc
complement
deposit
lung
fig
similar
associ
pathogenesi
ross
river
virusinfect
mice
influenza
viru
infect
like
complement
deposit
contribut
pulmonari
diseas
inflammatori
cell
recruit
cytokin
chemokin
kc
gcsf
higher
abund
lung
sarscov
wildtyp
mice
mice
known
promot
neutrophil
recruit
inde
significantli
neutrophil
observ
lung
sarscov
mice
mice
fig
interestingli
fewer
neutrophil
present
neutrophil
found
lung
mice
infect
sarscov
significantli
stain
major
histocompat
complex
class
ii
mhc
ii
costimulatori
molecul
fig
indic
state
activ
unpublish
data
laboratori
consist
demonstr
higher
neutrophil
count
lung
mice
sever
diseas
mice
mild
pathogenesi
addit
neutrophilia
human
sarscov
patient
associ
poor
outcom
infect
studi
nativ
rat
coronaviru
found
protect
pathogen
role
neutrophil
follow
infect
combin
data
demonstr
absenc
complement
provid
signific
improv
pulmonari
diseas
follow
sarscov
infect
suggest
nonpulmonari
caus
might
also
contribut
lack
weight
loss
mice
importantli
data
demonstr
sarscov
infect
activ
complement
system
systemat
well
lung
fig
wildtyp
mice
exhibit
increas
abund
serum
cytokin
chemokin
respons
sarscov
infect
fig
comparison
mice
particular
pyrogen
cytokin
present
higher
abund
lung
sera
mice
mice
also
abund
lung
mice
suggest
wildtyp
mice
develop
fever
respons
infect
contribut
weight
loss
respiratori
dysfunct
phenotyp
precis
mechan
complement
activ
follow
sarscov
infect
still
unclear
like
recognit
viral
spike
glycoprotein
partial
mediat
mbl
see
fig
supplement
materi
anaphylatoxin
produc
activ
complement
pathway
import
immunostimulatori
role
vascular
permeabl
inflammatori
cell
recruit
particular
note
role
caus
mast
cell
degranul
initi
cytokin
storm
promot
vascular
permeabl
contribut
acut
lung
injuri
furthermor
antibodi
blockad
recent
shown
protect
model
highli
suscept
merscov
mice
although
report
mast
cell
activ
follow
sarscov
merscov
infect
activ
observ
vitro
vivo
follow
infect
influenza
viru
may
occur
follow
sever
respiratori
infect
includ
coronavirus
mast
cell
releas
cytokin
includ
consist
inflammatori
profil
observ
follow
sarscov
infect
work
definit
conclud
complement
anaphylatoxin
mast
cell
activ
contribut
sarscov
pathogenesi
data
consist
possibl
concept
warrant
investig
complement
pathway
activ
hallmark
bacteri
infect
genet
defici
complement
pathway
result
enhanc
suscept
streptococcu
pneumonia
neisseria
meningitidi
haemophilu
influenza
infect
well
sepsi
interestingli
also
shown
sarscov
infect
stimul
classic
known
lipopolysaccharid
lp
receptor
import
recognit
mani
bacteri
infect
combin
data
suggest
host
recognit
sarscov
infect
may
activ
similar
pathway
recogn
bacteri
infect
lead
immun
signal
cascad
caus
system
diseas
enhanc
viral
pathogenesi
system
activ
complement
pathway
may
use
bacteri
infect
less
local
acut
viral
infect
sarscov
furthermor
complement
activ
conjunct
presenc
neutrophil
known
caus
increas
vascular
permeabl
condit
also
observ
follow
sarscov
infect
associ
poor
outcom
baselin
complement
activ
also
increas
age
consist
increas
sarscov
morbid
mortal
age
popul
final
previous
report
serum
level
predict
ard
develop
absenc
complement
anim
protect
bacteri
induc
shock
lung
data
consist
pathogen
role
found
complement
follow
sarscov
infect
work
demonstr
sarscov
infect
activ
complement
pathway
complement
signal
contribut
diseas
follow
infect
diseas
like
mediat
complement
protein
deposit
lung
well
system
complement
activ
inflamm
notabl
absenc
impact
viral
titer
unlik
observ
follow
influenza
viru
infect
despit
differ
notabl
merscov
influenza
virusinduc
acut
lung
injuri
pulmonari
inflamm
reduc
mice
treat
either
receptor
antagonist
antibodi
similar
treatment
might
effect
mitig
sarscov
diseas
sar
mer
influenza
common
diseas
manifest
includ
develop
acut
lung
injuri
given
larg
array
zoonot
strain
pois
crossspeci
transmiss
broadbas
inhibitor
emerg
coronaviru
infect
high
prioriti
pinpoint
precis
arm
complement
pathway
contribut
sarscov
help
identifi
therapeut
target
minim
unnecessari
inhibit
immun
respons
work
suggest
investig
anticompl
drug
treatment
coronaviru
infect
warrant
would
pair
well
direct
antivir
therapeut
stock
recombin
mouseadapt
sarscov
propag
titer
determin
vero
cell
store
singleus
aliquot
previous
describ
tissu
titer
determin
plaqu
assay
vero
cell
previous
describ
limit
detect
pfu
experi
use
live
viru
perform
class
ii
biolog
safeti
cabinet
certifi
biosafeti
level
laboratori
neg
air
pressur
redund
exhaust
fan
personnel
wore
person
protect
equip
includ
tyvek
suit
hood
power
airpurifi
respir
mous
experi
stock
number
stock
number
mice
purchas
jackson
laboratori
fb
mice
gener
provid
charl
jennett
unc
mice
provid
mark
heis
unc
anim
husbandri
experi
perform
accord
univers
north
carolina
chapel
hill
institut
anim
care
use
committe
guidelin
agematch
femal
mice
anesthet
mixtur
ketaminexylazin
intranas
inocul
l
phosphatebuff
salin
pb
pfu
sarscov
dilut
pb
mice
monitor
diseas
sign
weigh
interv
microarray
proteom
analysi
microarray
proteom
analys
perform
time
cours
accord
doserespons
studi
publish
gralinski
et
al
follow
method
proteom
data
experi
public
avail
pnnl
http
omicspnlgov
web
portal
briefli
mean
intens
abund
protein
graph
averag
mice
infect
mice
mock
infect
group
time
point
miss
absent
valu
score
howev
valu
observ
sampl
time
point
sampl
regist
singl
repres
detect
histolog
analysi
time
indic
figur
mice
euthan
use
overdos
isofluran
lung
tissu
fix
formalin
tissu
embed
paraffin
section
prepar
determin
extent
inflamm
tissu
patholog
tissu
stain
hematoxylin
eosin
score
blind
manner
sign
phenotyp
widespread
sever
phenotyp
platelet
count
bronchoalveolar
lavag
bal
immedi
follow
euthanasia
ml
pb
inject
lung
trachea
use
exel
safelet
cathet
tip
fisher
fluid
drawn
back
use
subsequ
analysi
two
hundr
fifti
microlit
bal
fluid
use
absolut
count
gross
cell
type
use
abaxi
vetscan
analyz
complement
deposit
stain
lung
section
sarscov
ross
river
viru
mockinfect
mice
stain
presenc
anim
histopatholog
laboratori
medicin
core
univers
north
carolina
sarscov
lung
sampl
test
mice
day
infect
pfu
viru
stain
perform
use
goat
antimous
primari
antibodi
mp
biomed
immunoblot
analysi
mice
perfus
pb
lung
tissu
dissect
homogen
lysi
buffer
mm
tri
ph
mm
nacl
nonidet
deoxychol
sodium
dodecyl
sulfat
sd
supplement
complet
proteas
inhibitor
cocktail
roch
total
protein
concentr
determin
use
coomassi
plu
assay
kit
pierc
dilut
serum
aliquot
protein
dilut
equal
volum
sd
sampl
buffer
sdspolyacrylamid
gel
electrophoresi
perform
protein
transfer
onto
polyvinyliden
fluorid
membran
biorad
membran
block
tween
incub
goat
antimous
antibodi
cappel
overnight
membran
wash
tween
incub
rabbit
antigoathorseradish
peroxidas
sigma
h
room
temperatur
wash
step
protein
visual
enhanc
chemiluminesc
amersham
accord
manufactur
instruct
flow
cytometri
follow
euthanasia
day
postinfect
mice
perfus
ml
pb
via
cardiac
punctur
lung
dissect
minc
incub
min
vigor
shake
clone
ebiosci
stain
cell
fix
paraformaldehyd
overnight
store
pb
acquisit
within
h
minimum
event
collect
use
lsrii
cytomet
becton
dickinson
analysi
complet
use
flowjo
softwar
version
treestar
sampl
first
evalu
subsequ
gate
mononuclear
cell
ii
doublet
exclus
iii
deadcel
exclus
base
uptak
fixabl
livedead
cell
discrimin
invitrogen
express
downstream
analys
report
cell
frequenc
normal
percentag
total
event
appropri
wholebodi
plethysmographi
respiratori
function
measur
use
wholebodi
plethysmographi
describ
menacheri
et
al
briefli
mice
load
individu
chamber
allow
acclim
min
measur
window
measur
record
everi
total
measur
per
time
point
per
mous
cytokin
chemokin
protein
analysi
small
center
lung
lobe
mous
homogen
ml
pb
briefli
centrifug
remov
debri
fifti
microlit
homogen
use
measur
cytokin
chemokin
protein
abund
use
bioplex
pro
mous
cytokin
assay
biorad
accord
manufactur
instruct
statist
analys
percent
start
bodi
weight
viral
titer
inflammatori
cell
number
evalu
statist
signific
differ
mannwhitney
test
student
test
use
graphpad
prism
softwar
access
number
microarray
data
previous
deposit
geo
databas
access
number
supplement
materi
articl
may
found
http
research
support
grant
niaid
nih
rsb
mth
rsb
rsb
vdm
anim
histopatholog
perform
anim
histopatholog
laboratori
medicin
core
univers
north
carolina
support
part
nci
center
core
support
grant
unc
lineberg
comprehens
cancer
center
unc
flow
cytometri
core
facil
support
part
cancer
center
core
support
grant
unc
lineberg
comprehens
cancer
center
funder
role
studi
design
data
collect
interpret
decis
submit
work
public
content
sole
respons
author
necessarili
repres
offici
view
nih
